{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"OS(Overall survival) is measured from date of study enrollment until death.","groups":[{"description":"Simvastatin and zoledronic acid:\n\n1. Simvastatin 80 mg PO daily starting two days before starting chemotherapy and stopping two days after chemotherapy.\n2. Zoledronic acid 4 mg IV over 15 minutes on day 1 and then monthly.","id":"OG000","title":"Simvastatin and Zoledronic Acid"}],"populationDescription":"Study was terminated and PI has left the institution. Sincere efforts were made to gather and report the data, however, no data is available for the study","reportingStatus":"POSTED","timeFrame":"At start of year 2 of follow-up on all surviving participants","title":"Overall Survival","type":"SECONDARY"}